Can peptides like BPC-157 actually treat cystic skin infections?

What did @jadaindia actually say?

Honestly? Almost nothing clinically useful, and that's not a criticism of the creator, it's just what the transcript shows. The video is essentially a back-and-forth of "help" and "do you want help" with no specific claims made about treatment, peptides, or cystic conditions. The caption does the heavy lifting here, describing recurrent cysts, repeated NHS antibiotic courses that aren't working, and significant impact on daily life including difficulty leaving the house.

So this fact-check is necessarily grounded more in the caption than the spoken words. The creator isn't pushing a product or making a therapeutic claim. They're asking for help from people who've been through something similar. That's a very different kind of content than the usual peptide promotion you see on TikTok, and it's worth acknowledging that upfront.

Does the science back up the antibiotic frustration?

Yes, completely. Antibiotic resistance and recurrent cystic infections are a genuine and well-documented clinical problem, not just an NHS failing. The frustration @jadaindia is describing maps onto a real pattern that dermatologists and GPs see constantly.

Recurrent cystic acne and infected sebaceous cysts are notoriously difficult to manage with antibiotics alone. A 2019 review by Walsh et al. in the British Journal of Dermatology found that antibiotic monotherapy for inflammatory acne produces diminishing returns over repeated courses, partly due to Cutibacterium acnes developing resistance patterns. A 2021 analysis published in Antibiotics (Thiboutot et al.) confirmed that long-term antibiotic use in acne patients correlates with increased colonization by resistant organisms without proportionate clinical benefit. The NHS framework for managing these conditions does often default to repeated antibiotic courses before escalating, which can feel like a loop to patients who aren't improving.

This doesn't mean the NHS is doing something wrong. It means the condition itself is hard, and systemic pathways take time to move through.

What did they get wrong, or right?

There are no factual errors to flag in the spoken content because no factual claims were made. The caption framing is emotionally honest and clinically plausible. The hashtag "cysticacnetreatment" might slightly mischaracterize the condition (infected cysts and cystic acne are related but not always the same thing), but that's a minor categorization issue, not misinformation.

What's worth flagging is the comment section dynamic this kind of video generates. Posts like this, with high view counts and visible distress, tend to attract well-meaning but unqualified advice, including suggestions to try peptides like BPC-157 or GHK-Cu for wound healing and skin repair. Those suggestions aren't supported by human clinical trial data for this specific use case. GHK-Cu has shown pro-collagen and anti-inflammatory properties in vitro (Pickart and Margolina, 2018, Biomedicines), but there is no peer-reviewed human trial demonstrating it resolves recurrent cystic infections. Anyone suggesting otherwise in the comments is getting ahead of the evidence.

What should you actually know?

If you're in the situation @jadaindia describes, recurrent cysts, antibiotics cycling without resolution, the clinical pathway forward usually involves a GP referral to dermatology for consideration of isotretinoin (for cystic acne specifically), incision and drainage for infected sebaceous cysts, or in some cases, minor surgical excision of the cyst wall itself, which antibiotics cannot address because they don't remove the cyst sac.

Peptide therapy is not a validated treatment for this condition. BPC-157 and TB-500 are studied for connective tissue repair in animal models. MK-677 and CJC-1295 work on growth hormone pathways. None of these have clinical trial data supporting their use in recurrent cystic skin infections. Trying unlicensed injectable peptides without medical supervision for a skin condition that requires proper diagnosis is not a safe path.

The most evidence-based next step for someone describing antibiotic treatment failure is requesting a dermatology referral in writing, specifically asking about isotretinoin eligibility or surgical options. That's not glamorous advice, but it's what the literature supports.